journal article·2013-08-09

Gd-doped BNNTs asT2-weighted MRI contrast agents

Gianni Ciofani, Adriano Boni, Lucia Calucci, Claudia Forte, Alessandro Gozzi, Barbara Mazzolai, Virgilio Mattoli

Nanotechnology· Volume 24· Issue 31
Publisher page

Abstract

This work describes, for the first time, doping of boron nitride nanotubes (BNNTs) with gadolinium (Gd@BNNTs), a stable functionalization that permits non-invasive BNNT tracking via magnetic resonance imaging (MRI). We report the structure, Gd loading, and relaxometric properties in water suspension at 7 T of Gd@BNNTs, and show the behaviour of these nanostructures as promising T2-weighted contrast agents. Finally, we demonstrate their complete biocompatibility in vitro on human neuroblastoma cells, together with their ability to effectively label and affect contrast in MRI images at 7 T.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Luminescence and Fluorescent Materials · Boron Compounds in Chemistry · Graphene research and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (34)

Show source-provided references
1. 10.1039/c0nr00335b10.1039/c0nr00335b ↗
2. 10.1016/j.mser.2010.06.00410.1016/j.mser.2010.06.004 ↗
3. 10.1002/smll.20120131510.1002/smll.201201315 ↗
4. 10.1021/ja807334b10.1021/ja807334b ↗
5. 10.1021/nn101985a10.1021/nn101985a ↗
6. 10.1016/j.actbio.2010.02.04410.1016/j.actbio.2010.02.044 ↗
7. 10.1016/j.ijpharm.2011.12.00210.1016/j.ijpharm.2011.12.002 ↗
8. 10.1021/jz100895s10.1021/jz100895s ↗
9. 10.1016/j.toxlet.2006.11.00110.1016/j.toxlet.2006.11.001 ↗
10. 10.1016/j.nano.2009.07.00310.1016/j.nano.2009.07.003 ↗
11. 10.1021/cr980440x10.1021/cr980440x ↗
12. 10.1039/c2cp41300k10.1039/c2cp41300k ↗
13. Sitharaman B · Chem. Commun. · 2005 · 391510.1039/b504435a ↗
14. 10.1002/cmmi.41010.1002/cmmi.410 ↗
15. 10.1016/j.biomaterials.2010.08.03410.1016/j.biomaterials.2010.08.034 ↗
16. 10.1155/2010/54045610.1155/2010/540456 ↗
17. 10.1016/j.materresbull.2012.11.01210.1016/j.materresbull.2012.11.012 ↗
18. 10.1016/j.jcis.2012.01.04910.1016/j.jcis.2012.01.049 ↗
19. 10.1016/j.bbrc.2010.03.03510.1016/j.bbrc.2010.03.035 ↗
20. 10.1006/abio.1997.217710.1006/abio.1997.2177 ↗
21. 10.1097/01.rli.0000184756.66360.d310.1097/01.rli.0000184756.66360.d3 ↗
22. 10.1002/cmmi.10010.1002/cmmi.100 ↗
23. 10.1097/RLI.0b013e3181ebd4e310.1097/RLI.0b013e3181ebd4e3 ↗
24. 10.1038/nnano.2010.20310.1038/nnano.2010.203 ↗
25. 10.1039/b920348f10.1039/b920348f ↗
26. Wong K · Proc. Int. Soc. Magn. Reson. Med. · 2008 · 16 · 1665
27. 10.1002/cmmi.41010.1002/cmmi.410 ↗
28. 10.1021/jp907891n10.1021/jp907891n ↗
29. 10.1002/adfm.20110282610.1002/adfm.201102826 ↗
30. 10.1021/cr100025t10.1021/cr100025t ↗
31. 10.1016/j.ccr.2008.05.00610.1016/j.ccr.2008.05.006 ↗
32. Wagner F M · J. Instrum. · 2012 · 7 · 0304110.1088/1748-0221/7/03/C03041 ↗
33. Ciani L · Expert Opin. Drug Discov. · 2012 · 7 · 101710.1517/17460441.2012.717530 ↗
34. 10.1039/c1jm11608h10.1039/c1jm11608h ↗